E. Weiderpass et al., RISK OF ENDOMETRIAL AND BREAST-CANCER IN PATIENTS WITH DIABETES-MELLITUS, International journal of cancer, 71(3), 1997, pp. 360-363
Diabetes mellitus patients have metabolic and endocrine alterations th
at could contribute to an increased incidence of hormone-related cance
rs. We assessed the incidence of endometrial and breast cancer among 8
0,005 women and the incidence of breast cancer among 73,847 men (total
of 153,852 patients) identified in the Swedish In-patient Register as
having been hospitalized for diabetes mellitus in the period 1965-198
3. These patients underwent follow-up through 1989 via the Swedish Can
cer Register and other nation-wide Swedish registers. The outcome meas
ures were standardized incidence ratios (SIR) based on age-, sex- and
calendar period-specific incidence rates from the entire Swedish popul
ation. To minimise the effect of selection bias, we excluded from the
calculation of incidence ratios the first year of observation and case
s diagnosed incidentally at autopsy. Only first cancers were considere
d for the estimates. A total of 328 endometrial cancers (SIR = 1.8; 95
% confidence interval [CI] 1.6-2.0), 1,145 female breast cancers (SIR
= 1.3; 95% CI = 1.2-1.4) and 13 male breast cancers (SIR = 2.0; 95% CI
= 1.0-3.4) were observed. We conclude that compared with the general
population, patients with diabetes mellitus have an increased incidenc
e of endometrial and breast cancers. (C) 1997 Wiley-Liss, Inc.